Wockhardt logo

Wockhardt PE ratio, market cap and valuation

NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap

Last close ₹1,801.70down ₹53.80 (2.90%)BSE ₹1,801.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,855.50.

52-week range of traded prices to 23 Oct 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
Market cap
₹29,276 Cr311th largest listed
P/E
71.6
P/B
5.9
Dividend yield
Nonein the last 12 months
ROE
8.8%
ROCE
7.4%
Debt to equity
0.40
Volume, NSE
8,79,19043.6% delivered

Wockhardt PE ratio and valuation against its own history

Each ratio on 23 Oct 2026 beside its median over each window. The ratios are on standalone accounts to Mar 2016, consolidated accounts Mar 2017 to Mar 2022, standalone accounts Mar 2023 and consolidated from Mar 2024. The PE ratio is the market cap over the profit of the last twelve months.

  • Price to earnings71.58today

    1 year

    Median 103.82

    Today is at or above 1% of the 173 days

  • Price to book5.93today

    1 year

    Median 5.15

    Today is at or above 59% of the 247 days

    3 years

    Median 4.94

    Today is at or above 75% of the 562 days

    5 years

    Median 2.10

    Today is at or above 86% of the 1,001 days

    10 years, since Nov 2018

    Median 1.57

    Today is at or above 92% of the 1,732 days

  • Price to sales8.21today

    1 year

    Median 7.75

    Today is at or above 58% of the 247 days

    3 years

    Median 7.25

    Today is at or above 78% of the 744 days

    5 years

    Median 3.13

    Today is at or above 87% of the 1,221 days

    10 years

    Median 1.94

    Today is at or above 93% of the 2,461 days

  • EV to EBITDA40.35today

    1 year

    Median 50.33

    Today is at or above 0.4% of the 247 days

    3 years

    Median 58.58

    Today is at or above 0.2% of the 562 days

    5 years

    Median 49.68

    Today is at or above 33% of the 1,001 days

  • Dividend yield0.00%today

    1 year

    Median 0.00%

    Today is at or above 100% of the 247 days

    3 years

    Median 0.00%

    Today is at or above 100% of the 744 days

    5 years

    Median 0.00%

    Today is at or above 100% of the 1,221 days

    10 years

    Median 0.00%

    Today is at or above 90% of the 2,461 days

  • Earnings yield1.40%today

    1 year

    Median 0.11%

    Today is at or above 100% of the 247 days

    3 years

    Median −0.84%

    Today is at or above 100% of the 744 days

    5 years

    Median −2.07%

    Today is at or above 100% of the 1,221 days

Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures

The twelve months: Filed 10 AugThe balance sheet: Filed 4 May

  • Price to earnings =Market cap÷Net profit, last twelve months₹409 Cr
  • Price to book =Market cap÷Net worth₹4,940 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹3,564 Cr
  • Enterprise value =Market cap+Borrowings₹2,125 Cr−Cash₹250 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹772 Cr
  • Market cap =Close×Shares in issue16,24,92,169at 30 Sep 2026

Consolidated accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Wockhardt financials ›

Wockhardt valuation at each year end

On the last trading day of each March, the month the company's year ends.Wockhardt dividend history

RatioMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Market cap (₹ crore)10,7627,9518,0354,9031,9124,5873,7702,2178,98523,14319,104
Price to earnings896.1363.1Owners' profit not statedOwners' profit not statedOwners' profit not stated5.5LossLossLossLoss868.4
Price to bookNo balance sheetNo balance sheetNo balance sheet1.80.81.31.11.1Shares changedShares changed4.2
Price to sales4.91.92.11.20.51.71.21.83.27.86.1
EV to EBITDANo balance sheetNo balance sheetOperating loss141.815.2333.222.416.6Shares changedShares changed43.2
Dividend yield0.00%1.39%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Earnings yield0.1%0.3%Owners' profit not statedOwners' profit not statedOwners' profit not stated18.0%−2.1%−5.7%−5.6%−0.8%0.1%
A ratio that does not exist on the day says why in its cell. The ratios are on standalone accounts to Mar 2016, consolidated accounts Mar 2017 to Mar 2022, standalone accounts Mar 2023 and consolidated from Mar 2024.

Wockhardt market cap, ten years

The last trading day of each month.

Market cap, ₹ crore

  • Market cap

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹31,151 Cr
Earnings per share
₹25.17
Book value per share
₹304.01
Dividends, last 12 months
None
Public's market cap
₹14,837 Cr

Against Pharmaceuticals

216 listed companies in Pharmaceuticals, each priced on its last trading day; Wockhardt is 21st among them by market cap. Each median leaves out Wockhardt itself and takes the other companies that have the figure.

Industry median P/E
28.1Across 155 other companies
Industry median P/B
2.8Across 186 other companies
Industry median EV/EBITDA
18.7Across 141 other companies
Industry median dividend yield
0.53%Across 89 other companies